• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
PGNY

PGNY

Progyny, Inc.

NASDAQHealthcareMedical - Healthcare Information ServicesUS

USD24.99

-0.13 (-0.52%)

Rating:B+

Company Profile

CEO

David J. Schlanger

IPO Date

2019-10-25

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Exchange

NASDAQ

Country

US

Market Metrics

Open

$25.02

Prev. Close

$25.12

Day Low

$24.70

Day High

$25.14

52W Low

$16.10

52W High

$28.75

Market Cap

$1.96B

Volume

1.34M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

51.5%

Avg Negative

10.7%

Avg Neutral

38.0%

News Feed

Progyny Grew 127% In The Last Year And Still Has Room To Run

Seeking Alpha·7/27/2021·↑ positive

Progyny, Inc. Announces Details for Its Second Quarter 2021 Results Report

GlobeNewsWire·7/22/2021·↓ negative

Progyny (PGNY) Moves to Strong Buy: Rationale Behind the Upgrade

Zacks Investment Research·7/22/2021·↑ positive

Progyny (PGNY) Sees Hammer Chart Pattern: Time to Buy?

Zacks Investment Research·7/13/2021·↓ negative

I'm selling Progyny this week [June 24th], and this is why!

Invezz·6/23/2021·↑ positive

Here's Why Progyny (PGNY) is a Great Momentum Stock to Buy

Zacks Investment Research·6/23/2021·↑ positive

Progyny's (PGNY) Shares March Higher, Can It Continue?

Zacks Investment Research·6/10/2021·↑ positive

Progyny, Inc. to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

GlobeNewsWire·6/4/2021·↑ positive

Earnings Estimates Moving Higher for Progyny (PGNY): Time to Buy?

Zacks Investment Research·6/2/2021·↑ positive

Welltok Welcomes Maven and Progyny to its Connect Ecosystem Family

PRNewsWire·5/19/2021·↑ positive